Cushing's syndrome variants secondary to aberrant hormone receptors

The secretion of cortisol and other steroids from adrenal tumors can be regulated by hormones other than corticotropin following the aberrant expression of several G-protein-coupled receptors (GPCRs). To date, ectopic receptors for gastric inhibitory polypeptide, beta-adrenergic receptor agonists, vasopressin V-2 and V-3 receptors), 5-hydroxytryptamine (5-HT7 receptor) and, probably, angiotensin II (AT, receptor) have been identified. Either increased expression or altered activity of eutopic receptors for vasopressin (V-1), luteinizing hormone/human chorionic gonadotropin, 5-HT (5-HT4 receptor) and leptin might also be involved. One or more aberrant receptors can be present in unilateral tumors and bilateral macronodular adrenal hyperplasia, at either the early subclinical or overt stages of hormone secretion. The identification of aberrant adrenal GPCRs offers the potential for novel pharmacological therapies that either suppress the endogenous ligands or block the receptor with specific antagonists.